Rubraca Tablet, Film Coated
Product Images NDC 82154-0785

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rubraca (NDC 82154-0785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaand Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Structural Formula)

Chemical structure of rucaparib, the active ingredient in Rubraca. The diagram shows the molecular arrangement of atoms and bonds characteristic of this oral tablet drug by pharmaand GmbH.*

FDA Label Image

2 (Figure1)

A Kaplan-Meier survival probability curve comparing Rubraca (solid line) and Placebo (dotted line) groups over 36 months. The x-axis represents months, and the y-axis shows survival probability from 0 to 1. The graph includes a legend identifying Rubraca and Placebo and a table below indicating the number of patients at risk and events at various time points for each group.*

FDA Label Image

5 (Figure2)

A Kaplan-Meier survival curve comparing the probability of an event over time in months between Rubraca and ARPI or Docetaxel treatment groups. The chart shows survival probabilities on the y-axis and time in months on the x-axis, with risk tables indicating numbers at risk and events below the graph.*

FDA Label Image

4 (Figure3)

A Kaplan-Meier survival curve comparing the probability over months for Rubraca versus ARPI or Docetaxel. The x-axis shows time in months, and the y-axis shows survival probability. The solid line represents Rubraca, and the dotted line represents ARPI or Docetaxel, with event counts and numbers at risk listed below the x-axis.*

FDA Label Image

200mg (Rubraca 200mg)

Label for Rubraca (rucaparib) tablets, 200 mg strength, containing 60 film-coated tablets. The label includes storage instructions, manufacturer information (pharmaand GmbH), and a barcode. It states the product is prescription only and advises keeping out of reach of children.*

FDA Label Image

250mg (Rubraca 250mg)

Rubraca (rucaparib) tablets 250 mg film-coated oral tablets. The label shows a package containing 60 tablets, marked Rx only, with a storage temperature range of 20°C to 25°C. The product is manufactured for pharmaand GmbH, made in Switzerland, and includes a barcode and NDC 82154-0784-1.*

FDA Label Image

300mg (Rubraca 300mg)

Rubraca 300 mg film-coated tablets oral packaging label, containing 60 tablets. The label shows the NDC 82154-0785-1 and states the product isRx only. Manufactured by pharmaand GmbH with additional manufacturing by Patheon, Inc. Made in Switzerland. Storage instructions and dosage reference are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.